Preclinical studies validate these direct anti-tumor effects across different agents: Liraglutide, for instance, demonstrates potent anti-cancer activity by suppressing HCC progression in mouse models, crucially exhibiting an anti-inflammatory effect by inhibiting the IL-6/STAT3 signaling pathway (Kojima et al., 2020
Peptide solutions were injected directly onto the analytical column (self-packed column, CSH C18 1.7 m beads, 300 m 30 cm) at a working flow rate of 5 L min 1 for 4 min
The peptide's activation of ERK1/2 and downstream transcription factors including Egr-1 drives expression of collagen synthesis genes while its enhancement of cellular migration ensures efficient fibroblast recruitment to sites requiring matrix deposition, creating optimal conditions for rapid yet organized tissue reconstruction
XPP treatment altered expression of genes involved in B cell differentiation and plasma cell IgE production, including cyclin d1 (CCND1), dual specificity phosphatase 4 (DUSP4), syndecan -1 (SDC1), erythroblastosis virus proto-oncogene 1 (ETS1), protein tyrosine phosphatase, receptor type, C (PTPRC), and IL-6R (Fig
